James Karras
22Patents
9h-index
26Co-inventors
71Inventor score
Filing activity: Mar 26, 1999 → May 22, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6210892A | Alteration of cellular behavior by antisense modulation of mRNA processing | Emerging Cross-Sectional Technologies | 245 | Expired |
| US7235653B2 | Oligonucleotide compositions and methods for the modulation of the expression of B7 protein | Emerging Cross-Sectional Technologies | 112 | Expired |
| US7033830B2 | Antisense modulation of MyD88 expression | Emerging Cross-Sectional Technologies | 60 | Expired |
| US6136603A | Antisense modulation of interleukin-5 signal transduction | Chemistry; Metallurgy | 37 | Expired |
| US6159694A | Antisense modulation of stat3 expression | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7176303B2 | Modulation of STAT5 expression | Chemistry; Metallurgy | 24 | Expired |
| US6727064B2 | Antisense oligonucleotide modulation of STAT3 expression | Emerging Cross-Sectional Technologies | 18 | Expired |
| US8168600B2 | Compositions and methods for topical delivery of oligonucleotides | Emerging Cross-Sectional Technologies | 15 | Expired |
| US7098192B2 | Antisense oligonucleotide modulation of STAT3 expression | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7307069B2 | Antisense oligonucleotide modulation of STAT3 expression | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7507810B2 | Compositions and their uses directed to IL-4R alpha | Chemistry; Metallurgy | 5 | Active |
| US7585968B2 | Compositions and their uses directed to thymus and activation-regulated chemokine (TARC) | Chemistry; Metallurgy | 4 | Expired |
| US7981868B2 | Antisense modulation of p38 mitogen activated protein kinase expression | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7709628B2 | Modulation of STAT5 expression | Chemistry; Metallurgy | 3 | Active |
| US8183363B2 | Antisense oligonucleotide modulation of STAT3 expression | Emerging Cross-Sectional Technologies | 3 | Active |
| US7115580B1 | Antisense modulation of B7 protein expression | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8765700B2 | Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions | Chemistry; Metallurgy | 1 | Active |
| US8623643B2 | Antisense oligonucleotide modulation of STAT3 expression | Emerging Cross-Sectional Technologies | 1 | Active |
| US8153603B2 | Compositions and their uses directed to IL-4R alpha | Chemistry; Metallurgy | 0 | Expired |
| US8722873B2 | Modulation of stat5 expression | Chemistry; Metallurgy | 0 | Active |
| US9776211B2 | Methods of filling wood voids and reducing waste in production of coated wood products | Emerging Cross-Sectional Technologies | 0 | Active |
| US8476421B2 | Modulation of stat5 expression | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.